The global, regional, and national burden of early, middle, and late-onset esophageal cancer and trends from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021

Authors:
  • ZLZongyuan Li
    Zongyuan Li
  • JLJili Li
    Jili Li
  • CYCheng Yu
    Cheng Yu
  • JHJianqi Hao
    Jianqi Hao
  • JSJiantong Sun
    Jiantong Sun
  • YCYi Chen
    Yi Chen
  • JZJian Zhang
    Jian Zhang
  • KZKejia Zhao
    Kejia Zhao

Abstract
Background: Although the overall burden has gradually decreased, our understanding of the differences in disease burden across various age groups remains incomplete and controversial. This study aimed to provide an updated estimate of the esophageal cancer burden, with a focus on temporal trends and age-specific patterns. Methods: We extracted data from the Global Burden of Disease Study (GBD) 2021. Esophageal cancer was grouped into three groups: early-onset (EOEC, 15–49 years), middle-onset (MOEC, 50–69 years), and late-onset esophageal cancer (LOEC, ≥70 years). Age-standardized rates (ASRs) ensured the comparability of age-standardized incidence rate (ASIR), mortality rate (ASMR), and disability-adjusted life-years (DALYs) rate (ASDR). Joinpoint regression identified temporal trends, and average annual percent change (AAPC) with 95% confidence intervals (CIs) was calculated. Furthermore, we conducted frontier, decomposition, cross-country inequality, and risk factor analyses. Bayesian age-period-cohort (BAPC) model was utilized to forecast future epidemiological trajectories from 2022 to 2035. Results: Globally, although the ASIR of EOEC declined from 1.95 per 100,000 in 1990 to 1.08 in 2021 with an AAPC of −1.9 (95% CI: −2.05 to −1.74, PConclusions: Our findings highlighted the need for targeted cancer control strategies that address population-specific needs, particularly with respect to age, gender, and sociodemographic disparities.

This publication has 51 references indexed in Scilit: